Tandex A/S

Denmark · owned by Theilvig Heart Holding ApS (Denmark) · tandex.dk · 2 vendors

Tandex A/S is a Danish company specializing in oral care products, including toothbrushes, interdental brushes, and dental floss. They focus on developing high-quality products for effective dental hygiene.

Resilience scores

Technology vendors

Insights

Last updated 2026-09-17 · revision 2

2 direct vendors, 45 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 3/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Tandex A/S demonstrates low migration readiness due to several critical factors. The most significant challenge is the complete absence of information regarding its internal tech stack and key technologies. Without knowing the current architecture (e.g., legacy, monolithic, cloud-native, containerized), it is impossible to accurately estimate the technical effort, cost, and complexity of a migration. The company operates within a highly regulated environment, subject to GDPR and EU Medical Device Regulation (MDR), with likely applicability of NIS2. These regulations impose stringent compliance requirements that would add significant complexity and cost to any migration, particularly concerning data protection, device certification, and cybersecurity. Data residency requirements are also unknown but likely lean towards EU residency, adding further constraints. Financial stability, crucial for funding a migration, is also not publicly available. Furthermore, while vendor geographic diversity exists, the company relies on a low number of services (two), which, according to the assessment guidelines, indicates a potentially high vendor lock-in risk, making it challenging to transition away from existing providers. Overall, the numerous unknowns and inherent complexities of the regulatory landscape point to a challenging and high-risk migration scenario.

Compliance

6 in-scope frameworks identified; showing 3.

EU Cosmetics Regulation — Assessment Required

This regulation applies to cosmetic products sold in the EU. Tandex A/S manufactures oral hygiene products that may be classified as cosmetics if they are intended for cleaning and maintaining the health of teeth and gums without a medical purpose.

Products like toothbrushes and dental floss, if not classified as medical devices, would likely fall under this regulation. Non-compliance could lead to product recalls and fines. The risk is medium as the safety requirements are stringent but well-established.

Evidence: https://www.cirs-group.com/en/cosmetics/compliance-with-the-eu-cosmetic-regulation, https://formulator.online/cosmetic-ingredient-compliance-eu-us/, https://www.chemsafetypro.com/Topics/Cosmetics/Regulatory_Lists_of_Cosmetic_Ingredients_Banned_Cosmetic_Ingredients,_Restricted_Cosmetic_Ingredients_and_Positive_Lists.html, https://laegemiddelstyrelsen.dk/en/licensing/medicine-or-not/special-classifications/dental-care-products/, https://smile-ohm.co.uk/2023/03/09/quality-reliable-tools-from-tandex/

GDPR (source) — Assessment Required

The General Data Protection Regulation (GDPR) applies to any organization established in the EU/EEA that processes personal data. Tandex A/S is headquartered in Denmark and therefore falls within the scope of GDPR.

As a company operating in the EU, Tandex A/S processes personal data of employees and likely customers and suppliers. Non-compliance with GDPR can result in significant fines. The risk is medium as the volume of sensitive data is likely moderate.

Packaging and Packaging Waste Directive — Assessment Required

This directive, implemented in Danish law, requires producers to take responsibility for the packaging they place on the market. This includes financing the collection and recycling of packaging waste.

As a manufacturer of consumer goods, Tandex A/S is subject to producer responsibility obligations for packaging. Failure to comply can result in fines and restrictions on market access. The risk is medium due to the direct financial and operational impact.

Evidence: https://epssw.com/blog/compliance-guide-for-the-eus-packaging-and-packaging-waste-regulation, https://circular-cities-and-regions.ec.europa.eu/support-materials/eu-regulations-legislation/packaging-and-packaging-waste-directive-ppwd-directive, https://www.naturvardsverket.se/en/guidance/extended-producer-responsibility-epr/packaging-and-packaging-waste-regulation-ppwr/, https://www.gtlaw.com/en/insights/2025/8/eu-packaging-and-packaging-waste-regulation-new-compliance-requirements-for-e-commerce, https://www.greif.com/understanding-the-new-eu-packaging-and-packaging-waste-regulation-ppwr/, https://www.dentaltix.com/en/tandex

Financials

Three-year financials

Financial Resilience Score: 5/10

Tandex A/S is a small, mature Danish niche manufacturer with a stable but sub-scale financial profile. Equity has remained remarkably stable in a narrow DKK 10.0–10.6M band across four reported years, absorbing alternating profit and loss years without capital injections. This indicates disciplined ownership and no aggressive dividend extraction, providing a modest cushion against downturns. The company benefits from a nearly century-old brand (founded 1931), a defensible 'Made in Denmark' positioning as the only Danish domestic producer of prophylaxis products, and group backing via parent Theilvig Heart Holding ApS. However, the business operates on very thin margins with gross profit oscillating between DKK 4.5M and 6.8M and EBIT swinging between roughly -DKK 0.5M and +DKK 1.3M. One bad year erases the prior year's earnings. FY2025 showed a sharp ~30% contraction in gross profit and a workforce reduction from 11 to 7 average employees, suggesting lost volume, distributor issues, or restructuring. The category is commoditized with intense competition from global majors (Colgate, P&G, TePe, Curaprox) and low-cost Asian brands. Export exposure to politically volatile markets (Turkey, India, Russia) adds sanctions and logistics risk, particularly for Russian sales. Overall resilience is moderate — the balance sheet is stable but earnings power is fragile.

Key strengths: Stable equity base around DKK 10M across 4+ years, Nearly century-old brand (founded 1931) with strong heritage, Only Danish domestic manufacturer of prophylaxis products, Group backing from Theilvig Heart Holding ApS, Diversified product line (toothbrushes, SOLO, FLEXI, gel, floss, picks), 100% Danish-owned with registered capital of DKK 6M, Headcount rebuilt to 17 in mid-2026 after 2025 low

Risk factors: Very small scale with thin operating margins, Sharp FY2025 contraction: gross profit -30%, headcount cut ~36%, Two loss years out of four (2023 and 2025), Category commoditization and competition from global majors and Asian low-cost brands, Export concentration in volatile markets (Turkey, India, Russia), Sanctions/logistics risk from Russian exposure since 2022, Inbound supply-chain dependence on Indian component suppliers, Gross profit peaked in 2022 — broadly flat-to-declining trend

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report